Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Existe información en español para pacientes y cuidadores, para acceder, haga clic sobre “Select” al lado de “I am a U.S. Patient / Caregiver”.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CIBINQO Principal Display Panel (abrocitinib)

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label

ALWAYS DISPENSE WITH
MEDICATION GUIDE

Pfizer
NDC 0069-0235-30

CIBINQO
(abrocitinib) tablets

50 mg

Do not crush, split, or chew the tablets.

30 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 100 mg Tablet Bottle Label

ALWAYS DISPENSE WITH
MEDICATION GUIDE

Pfizer
NDC 0069-0335-30

CIBINQO
(abrocitinib) tablets

100 mg

Do not crush, split, or chew the tablets.

30 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 100 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 200 mg Tablet Bottle Label

ALWAYS DISPENSE WITH
MEDICATION GUIDE

Pfizer
NDC 0069-0435-30

CIBINQO
(abrocitinib) tablets

200 mg

Do not crush, split, or chew the tablets.

30 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 200 mg Tablet Bottle Label
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event